Erbitux (cetuximab), a so-called monoclonal antibody, works by blocking cellular receptors, preventing tumor cells from receiving signals that tell them to grow and divide. The <a href="http://drugstore-inc.com/forum/pharmacists/lexapro-450-chytochrome-drug-interaction-question-25670.html">drug</a> has been used successfully in metastatic colon cancer and now appears to also benefit patients with head and neck cancers.http://drugstore-inc.com/newdrugs/velcade-black-triangle-bortezomib-approved-previously-untreated-multiple-myeloma-1115.html |